Neelam, S., Mellon, J., Wilkerson, A., & Niederkorn, J. Y. (2019). Defective FasL expression is associated with increased resistance to melanoma liver metastases and enhanced natural kill cell activity. Melanoma Res.
Citación estilo ChicagoNeelam, Sudha, Jessamee Mellon, Amber Wilkerson, y Jerry Y. Niederkorn. "Defective FasL Expression Is Associated With Increased Resistance to Melanoma Liver Metastases and Enhanced Natural Kill Cell Activity." Melanoma Res 2019.
Cita MLANeelam, Sudha, Jessamee Mellon, Amber Wilkerson, y Jerry Y. Niederkorn. "Defective FasL Expression Is Associated With Increased Resistance to Melanoma Liver Metastases and Enhanced Natural Kill Cell Activity." Melanoma Res 2019.
Precaución: Estas citas no son 100% exactas.